Your browser doesn't support javascript.
loading
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
Lephart, Paul R; Bachman, Michael A; LeBar, William; McClellan, Scott; Barron, Karen; Schroeder, Lee; Newton, Duane W.
Afiliação
  • Lephart PR; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: plephart@umich.edu.
  • Bachman MA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • LeBar W; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • McClellan S; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Barron K; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Schroeder L; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Newton DW; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
Diagn Microbiol Infect Dis ; 99(1): 115200, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32980807
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Teste de Ácido Nucleico para COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Teste de Ácido Nucleico para COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article